Recross P3 Occluder (P3O) System

DEVICE2 trials

Sponsors

Recross Cardio, Inc.

Conditions

Cryptogenic StrokePFOPFO - Patent Foramen OvalePFO-associated StrokePatent Foramen Ovale

Unknown Phase

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

RecruitingNCT07172464

Recross Cardio, Inc.Cryptogenic Stroke, Patent Foramen Ovale, PFO +2

Start: 2025-10-09End: 2031-02-01Target: 30Updated: 2026-07-27

Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study

RecruitingNCT07698951

Recross Cardio, Inc.Cryptogenic Stroke, Patent Foramen Ovale, PFO +2

Start: 2026-06-17End: 2029-12-01Target: 15Updated: 2026-07-13